Alkeon Capital Management LLC Relmada Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

  • $60.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$16.93 - $26.82 $1.69 Million - $2.68 Million
-100,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$21.86 - $34.77 $1.09 Million - $1.74 Million
50,000 Added 100.0%
100,000 $2.62 Million
Q4 2020

Feb 16, 2021
BUY
$29.88 - $39.8 $1.49 Million - $1.99 Million
50,000 New
50,000 $1.6 Million

Others Institutions Holding RLMD

# of Institutions
88
Shares Held
13.5M
Call Options Held
85.8K
Put Options Held
42.8K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $96.4M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email